The data behind discovery.

St. Jude Cloud at ASCO 2019


St. Jude Children’s Research Hospital, a global leader in pediatric cancer research, has undertaken an unprecedented global commitment to share its extensive data and powerful tools with the international research community. From vast genetic sequencing data to a constantly growing set of unmined clinical genomics data, St. Jude is at the forefront of the powerful new data-sharing models that are transforming cancer research.

At the 2019 Annual Meeting of the American Society of Clinical Oncology in Chicago, be sure to make time to learn about the new datasets and powerful analysis tools that St. Jude is sharing with the world research community.

Cloud logo

St. Jude Cloud is a data-sharing resource for the global research community. More than 600 clinical genomic cases are now available in St. Jude Cloud. Researchers can explore unique next-generation sequencing data and analysis tools, including the newly launched GenomePaint, for pediatric cancer and other life-threatening diseases.

Want to know the latest from St. Jude Cloud?


Explore the latest new features from the world's largest repository of pediatric cancer genomics data:


Meet the Scientists

Saturday, June 1, 1:00-2:00 p.m.
Sunday, June 2, 11:00 a.m.-noon
Location: 3064

Alex Gout, PhD

Alex Gout, PhD

Senior bioinformatics research scientist in the Computational Biology department at St. Jude Children's Research Hospital.

Scott Newman, PhD

Scott Newman, PhD

Group leader in bioinformatics analysis in the Computational Biology department at St. Jude Children's Research Hospital.

Poster Session Discussion

Real-time sharing of comprehensive clinical genomics sequencing in St. Jude Cloud

Abstract 10019
Sunday, June 1, 1:15-2:45 p.m. 
Location: S504

Scott Newman, PhD, reports on the clinical genomic information available through St. Jude Cloud on June 1. The poster and subsequent discussion will include comprehensive whole genome, exome and transcriptome genomic sequencing data. The data is from normal and tumor tissue of more than 1,000 children with pediatric cancer, as well as clinical patient information. An analysis of data from the first 253 cases found 78% of patients had clinically relevant mutations, this includes 11-16% that less comprehensive sequencing might have missed. The announcement at ASCO officially launches the beginning of a new clinical genomics era at St. Jude. The institution anticipates adding comprehensive clinical sequencing data from additional cases at regular intervals, totaling about 500 each year, with a goal of making this richly annotated dataset available as soon as possible to researchers and clinicians, rather than waiting for it to accompany a publication.

Media Contacts

For onsite interviews or media requests, contact:

Marvin Stockwell
Director of Media Relations


Connect with Us

Connect with @StJudeResearch during ASCO and use #ASCO19.
Visit us at Booth #3804